Active Ingredient(s): Desmopressin Acetate
FDA Approved: * June 21, 2018
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nocdurna Overview

Desmopressin, sold under the trade name DDAVP among others, is a medication used to treat diabetes insipidus, bedwetting, hemophilia A, von Willebrand disease, and high blood urea levels.[1] In hemophilia A and von Willebrand disease, it should only be used for mild to moderate cases.[1] It may be given in the nose, by injection into a vein, by mouth, or under the tongue.[1] Common side effects include headaches, diarrhea, and low blood sodium.&...

Read more Nocdurna Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Nocdurna Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Desmopressin Acetate
  • Injection: 0.004mg/ml, 0.015mg/ml, 4mcg/ml
  • Solution: 0.01%
  • Spray: 0.83mcg/0.1ml, 1.66mcg/0.1ml
  • Spray, Metered: 0.00083mg/spray, 0.00166mg/spray, 0.01mg/actuation, 0.01mg/spray, 0.15mg/spray, 1.5mg/spray, 150mcg/actuation
  • Tablet: 0.0277mg, 0.0553mg, 0.1mg, 0.2mg, 27.7mcg, 53.3mcg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nocdurna: (4 results)

Sorted by National Drug Code
  • 54436-325 Nocdurna 27.7 ug/1 Sublingual Tablet by Antares Pharma, Inc.
  • 54436-350 Nocdurna 55.3 ug/1 Sublingual Tablet by Antares Pharma, Inc.
  • 55566-5050 Nocdurna 27.7 ug/1 Sublingual Tablet by Ferring Pharmaceuticals Inc.
  • 55566-5070 Nocdurna 55.3 ug/1 Sublingual Tablet by Ferring Pharmaceuticals Inc.

Other drugs which contain Desmopressin Acetate or a similar ingredient: (7 results)